Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
16.60
-0.30 (-1.78%)
At close: Jun 27, 2025, 4:00 PM
15.90
-0.70 (-4.22%)
After-hours: Jun 27, 2025, 4:00 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $248.23 million as of June 27, 2025.
Market Cap
248.23M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$16.60
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $111.34M to $248.23M, an increase of 122.95%. That is a compound annual growth rate of 512,019,294,881,764.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 252.72M | 126.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.46B |
| Johnson & Johnson | 366.06B |
| AbbVie | 329.26B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 273.62B |
| Abbott Laboratories | 239.92B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |